Lumos Diagnostics Holdings Limited (LDXHF) Q4 2025 Earnings Call Transcript

George Kopsiaftis

Hello everyone, welcome to the Lumos Diagnostics’ FY ’25 results investor briefing. My name is George Kopsiaftis, and I’ll be your moderator for today. The webinar is being recorded today and will be made available on the Lumos website over the next couple of days.

With us this morning, we have Lumos Diagnostics’ CEO, Doug Ward. We have CFO, Barrie Lambert, Paul Kase is the Senior Vice President of Commercial Operations; and Annie Bell, is our Vice President of Medical Affairs. Good morning to you all.

Barrie Lambert
Chief Financial Officer

Good morning, George.

George Kopsiaftis

So the format for today is for the team to walk you through the presentation that was released to the ASX this morning. The presentation should take around 30 to 35 minutes. And this will then be followed by a question-and-answer session. [Operator Instructions] That concludes housekeeping for today. So I’d like to now hand it over to Doug to get us started. Thank you, Doug.

Douglas Ward
CEO, MD & Director

Thank you very much, George. Hello, everyone. Really pleased to be with you today to go through our year-end 2025 financials, and a number of other updates that we’ve had and announcements that we’ve made over the last few weeks.

This, quite frankly, I think, is one of the most positive webinars that we’ve had to date. And we’re really excited to bring in this today, and I’m really pleased to have both Paul and Annie with us given some of the detail in regard to sales as well